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tion therapy with half-dose r:PA and abciximab reduces the rate of reinfarction across a 
broad range of patients compared with r-PA alone. The long-term implications of these 
findings on 1-year mortality awaits definition. 
2:15 p.m. 
828-2 The Abciximab ST-Recovery ON AMI (ASTRONAMI) 
GUSTO V Substudy: Enhanced Early Speed, Stability, 
and Quality of Reperfueion With AntI-Platelet 
Augmented Thrombolytic Therapy for ST-Elevation AMI 
Mitchell W. Krucoff, Cynthia L. Green, Anatoly Langer, Brian Giblet, Paul W. Armstrong, 
Kathleen M. Trollinger, Suzanne W. Crater, Michael A. Lincoff, Robert M, Califf, Eric J, 
TOpoI, The ASTRONAMI-GUSTO V Investigators, Duke University Medical Center~Duke 
Clinical Research Institute, Durham, North Caro/ina, Cleveland Clinic Foundation, 
C/eve/and, Ohio. 
Background: In the GUSTO V study combined Rx with abciximab and low dose rPA was 
compared to full dose rPA alone in pts with ST elevation MI. Modality with Combo Rx 
was non-inferior, Mechanistic differences were not reported. 
Methods: In the ASTRONAMI substudy the speed, stability and microvascular quality of 
reperfusion were quantified by blinded core lab analysis of ST recovery from Rozinn 152 
continuous digital 12-lead ECG recordings as: 1 ) time (minutes) from onset of Rx to a) 1st 
50% ST recovery from peak (1 st 50% ST} and b) >4 hrs with >50% ST recovery (STA- 
BLE ST); 2) recurrent ischemia (RE-ST, as % of pts with ST re-elevation >150uV over 
recovery levels; and 3) ST level vs. time trend curve area (ST AREA in uV-min), respec- 
tively. 
Results: A total of 4,992 pt hrs of monitoring totaling 299,520 ECGs were analyzed from 
207 pts (108 Combo Rx, 99 rPA Rx). Clinical descriptors, time from chest pain to Rx, time 
to ST monitoring, duration of monitoring and peak ST levels were comparable. ST recov- 
e~ results were: 
Descriptor rPA Rx Combo Rx P value* 
1 =t 50=/= ST (%) 46 (19.0, 92.6) 34.0 (0, 66) .042 
STABLE ST (min) f 00 (42, 162) 65 (0, 112) .002 
RE-ST (%) 40.2 30.1 . f 55 
ST AREA (uV-min) 4782 (259, 9820) 2576 (0, 7716) .047 
* continuous variables: two-sample t-test, Wilcoxon rank sum test; discrete variables: 
likelihood ratio chi-square, Fisher's exact text. 
Conclusion: Thus, combined Rx with abciximab and low dose rPA improves the speed, 
stability and microvascutar quality of reperfusion in ST-elevation MI compared to rPA 
alone. 
2:30 p.m. 
828-3 Combination Tenecteplase and Abciximab Results in 
More Complete ST Resolution: Findings from the 
ASSENT 3 ECG Subatudy 
Yulina Fu, Galen Wagner, Shaun Goodman, Frans Van de Werf, Christopher B. Granger, 
Paul W. Armstrong, for the ASSENT 3 Investigators, University of A/berta, Edmonton, 
A/berta, Canada. 
The ASSENT 3 study documented that the two experimental arms i.e. combination 
tenectsplase plus enoxaparin or half-dose tenecteplase and abciximab reduced the fre- 
quency of ischemic complications of acute myocardial infarction. The mechanism(s) for 
this benefit is unclear but combination therapy with fibrinolytic and glycoprotein lib/Ilia 
inhibitors has previously achieved more effective early reperfusion in phase 2 anglo- 
graphic trials whereas angiographic evaluation with low molecuJar weight heparin has 
shown less reocclusion. 
Accordingly we analyzed sequential ECG's at baseline, 60 and 180 minutes after enroll- 
ment in all patients in the ASSENT 3 study, in order to evaluate the 3 treatment groups 
(tenecteplase and enoxaparin [TNK/ENOX]; half dose tenecteplase and abciximab [1/2 
TNK/ABCX]; tanecteplase and unfractionated heparin [TNK/UH]). Amongst the 75% of 
the 6,095 patients who had technically suitable ECG data free of confounding factors, ST 
resolution compared to baseline is shown in the table, 
These data, in a large comprehensively studied AMI population, suggest better early 
myocardial perfusion with combination TNK-abciximab than TNK with either ENOX OR 
UH alone. They also suggest the clinical benefit of enoxaparin in ASSENT 3 is modu- 
lated by a mechanism different han early repertusion occurring later in the ischemic pro- 
cess. 
TNK/ENOX 1/2 TNK/ABCX TNK/UH 
60 min ECG n=1,506 n=1,472 n=1,483 
>=70% resolution 28.9 33.4* 31.9 
30-70% resolution 33.9 32.5 31.4 
<30% resolution 37.3 34.1 36.7 
180 min ECG n=1,463 n=1,461 n=1,416 
>=70% resolution 50.0 59.1 ** 48.0 
30-70% resolution 32.5 29.6 31.5 
<30% resolution 17.5 t 1.3 20.5 
*p=0.02 **p<0.001 
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828-4 Differential Impact of Antlthrombotlc Treatments 
Combined With Tenecteplaae in the Elderly With Acute 
Myocardial Infarction: Results From ASSENT-3 
Christooher B. Granoer. John H. Alexander, Emmanuel Lesaffre, Lars Wallentin, Paul W. 
Armstrong, Frans Van de Werf, Duke C/in/ca/Research Institute, Durham, North 
Carolina, Leuven Coordinating Centre, Leuven, Belgium. 
Background: Among patients with acute myocardial infarction (MI), the elderly are at par- 
ticularly high risk for death and bleeding complications, including with more aggressive 
antithrombotic strategies. 
Methods: In order to provide insight into risk and benefit in the elderly, we examined 
patients from the ASSENT-3 Trial with ST elevation MI, who were treated with tenect- 
eplase (TNK) and randomized to unfractionated heparin (UFH), enoxapadn, or abcix- 
imab with low dose heparJn (and half-dose TNK), 
Results: Of the 6095 patients enrolled, 13% (767) were >75 years of age. Compared to 
younger patients, patients > 75 had higher rates of death (17.9 vs 4.3%), intracraniat 
hemorrhage (ICH, 1.6 vs 0.8%), and bleeding. Older patients had higher rates of the effi- 
cacy + safety composite (death, reMI, refractory ischemia, ICH, and major bleeding) with 
abciximab than with enoxaparin or UFH (table), and the treatment effect of abciximab vs 
UFH was significantly less in older than in younger patients (interaction p<0.05). 
Conclusions: Elderly patients with acute MI are at high risk of death and bleeding, 
Although TNK with either enoxaparin or abciximab appeared to be more effective than 
with standard UFH in younger patients, TNK with abciximab as dosed in this trial was sig- 
nificantly less effective and may be unsafe in the elderly. For elderly patients, develop- 
ment of treatments with greater safety and effectiveness remains a high priority. 
>75 years (11=767) 
UHF Enoxaparin Abciximab p 
Death, reMI, refractory ischemia, ICH, 28.0 25.5 36.9 0.01 
major bleed (%) 
30-day death (%) 15.9 18.6 22.3 0.11 
ReMI (%) 6.3 2.3 3.0 0.07 
Major bleeding (%) 4.1 7.2 13.3 0.001 
ICH (%) 0.74 1.52 2.58 0.26 
3:00 p.m. 
828-5 Lack of Improvement in ST Segment Resolution After 
the Combination Treatment of Abcixlmab With 
Reteplase Compared to Reteplase Alone for Acute 
Myocardial Infarction: Results From the GUSTO V- 
RESTART Subatudy 
Femando A. Cure, Marco Roffi, Narcis Pasca, Katherine E. Wolski, Eric J. Topoi, Michael 
S. Lauer, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: The combination of abciximab during reperfusion therapies is believed to 
enhance tissue level and microvascular perfusion. Resolution of ST-segment elevation 
after administration of thrombolytic therapy in patients with acute myocardial infarction is 
a marker of myocardial reperfusion and has an important predictive value of mortality. 
This study compared the extent of 60-minute ST-segment elevation resolution of patients 
treated with full dose of reteplase versus half-dose reteplase in combination with abcix- 
imab given at the normal dose from the GUSTO V-AMI trial. 
Methods: From a total of 16.588 patients enrolled in the GUSTO V-AMI trial, 1764 were 
prospectively included in the RESTART substudy and were randomized to the combina- 
tion of full dose abciximab and half dose of reteplase or full dose of reteplase alone. A 
baseline and 60-minute ECG was analyzed by a core lab to categorize 4 groups: com- 
plete resolution (>70%), partial resolution (<70%-30%), no resolution (<30%) and wors- 
ening ST-segment. 
Results: There was no difference in the clinical baseline variables between the two treat- 
ment groups, The results are summarized in the table. 
Reteplase Reteplase + Abciximab p value 
(n=871) (n=893) 
Complete Resolution (%) 32 34 0.37 
Partial Resolution (%) 29 27 0.35 
No Resolution (%) 19 18 0.59 
Worsening ST-segment (%) 20 20 0.95 
30-day Mortality (%) 5.1 4.7 0.73 
Conclusion: Patients treated with reduced doses of reteplase when administered in 
combination with abciximab are associated with similar extent of ST-segment elevation 
resolution as those treated with full dose reteplase alone. 
3:15 p.m. 
828-6 Risk and Benefit of  Half-Dose Lytlc Plus Abciximab 
Versus Lytic Alone for ST-Elevation Myocardial 
Infarction: A Mate-Analysis 
Freak W. Verheuat. University Medical Center Nijmegen, Nijmegen, The Netherlands. 
Background Angiogrephic trials have shown improved 60 and 90 minutes coronary 
patency with half-dose lytic plus abciximab versus lytic alone in ST-elevation MI (STEMI). 
These strategies have recently been evaluated in 2 phase III msgatrials for efficacy and 
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safety. 
Methods Rates of 30-day mortality, intracranial hemorrhage (ICH), severe extracranial 
bleeding and transfusions were collected from the half-dose lyric plus abeiximab arms 
and the lytic alone arms of TIMI-14 and SPEED, and the megatrials GUSTO-V and 
ASSENT-3. 
Results In total 23,322 were randomized in the 4 trials: 10,713 in the half-dose lyric plus 
abciximab groups and 12,609 in the I/tic alone groups. 30-Day death was similar in both 
groups: 5.8% vs 5.8% (RR 0.99, 98%CI 0.81-1.10, p = 038) as was the rate of ICH: 
0.7% vs 0.7% (RR 0.98, 95%CI 0.49-1.96, p = 0.96). But, severe extracranial bleeding 
was very significantly increased by half-dose lyric plus abciximab (L+A) compared to lytic 
alone (L), as was the need for transfusion: 5.6% vs 3,9% (RR 1.46, 95%CI 1.30-1.84). 
Conclusion In comparison to a fibdnolytic alone, reduced dose fibrinolytic combined with 
abciximab for STEMI significantly increases severe bleeding and transfusion with 50% 
without reducing mortality or hemorrhagic stroke. This costly combination should be 
avoided as a routine, and trial designs evaluating the combination for facilitated primary 
PCI or for prehospital/ER use prior to primary PCI should be reconsidered. 
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1122B Plaque Instability: Local and Systemic 
Factors 
Monday, March 18,2002, 3:00 p.m.-5:00 p.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 4:00 p.m.-5:00 p.m. 
1122B-31 Mult ip le  Plaque Ruptures in Patients With Acute 
Myocardial Infarction: An Angioscopic Evidence of 
Systemic Cause of Plaque Instabi l i ty  
Yoshiharu Fuiimod. Hiroshi Modo, Kuniko Terasawa, Takashi Shiga, Masaru Hatano, 
Masaaki Osegawa, Yasumi Uchida, Toshihiro Modta, Narita Red Cross Hospital, Narita, 
Japan, University of Tokyo, Tokyo, Japan. 
Background Onset of acute coronary syndromes is well known to be induced by rupture 
of the vulnerable coronary plaques. There is a hypothesis that some systemic factors are 
important as the cause of plaque instability. Therefore, we observed coronary arteries in 
patients with acute myocardial infarction by angioscopy to reveal whether multiple 
plaques ruptured simultaneously or not, in order to certify the hypothesis, 
Methods We observed infarct-relatad coronary arteries by angioscopy in 102 patients 
with AMI after 4.7±5.1 hours from the onset, just before emergent interventional revascu- 
ladzation. We defined the plaques as ruptured, only when there was an ulcer or erosion 
with or without hrombus. The results were contrasted with coronary angiography. 
Results The length of the coronary segments angioscopically observed were 4.1±2.2 
cm. Multiple plaque ruptures were observed in 10 patients (10%). Of those, we found two 
ruptured plaques in 9 patients, and four ruptured plaques in 1 patient. All ruptured 
plaques culprit for obstruction accompanied massive thrombi. Non-culpdt ruptured 
plaques were yellow in color, and mural red thrombi were lying on the ulcers or erosions 
except two plaques. Those two non-culprit ruptured plaques without thrombi were less 
yellowish and both dissected. One non-culprit plaque ruptures alone could be found by 
coronary angiography. Conventional risk factors for coronary artery disease in patients 
with multiple plaque ruptures were not different from those with single plaque rupture. 
Conclusions These angioscopic findings demonstrated that plaque rupture did not nec- 
essarily limited in the culprit coronary plaques, and suggested that some systemic, but 
not local factors have to account for them. The results in this study support the hypothe- 
sis that some systemic factors are important as the cause of plaque instability. 
1122B-32 Natural  H is tory  of  Mul t ip le  Complex  Coronary  Plaques 
in Patients With Acute Myocardial Infarction: A Study 
With Coronary Angiography 
Sano-Gon Lee, Cheol Whan Lee, Myeong-Ki Hong, Seong-Wook Park, Seung-Jung 
Park, Ulsan University Hospital, Ulsan, South Korea, Asan Medical Center, Seoul, South 
Korea. 
Background: Patients with acute myocardial infarction(AMI) may have multiple complex 
coronary plaques that is not limited to the culprit lesions. However, it is unknown whether 
they tend to progress in severity, regress, or remain stable. The aim of this angiographic 
study is to document he prevalence of multiple complex plaque in patients with AMI and 
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to evaluate the natural history of these lesions. Method: We consecutively enrolled 229 
patients in whom coronary angiography was performed to treat AMI with primary angio- 
plasty. Baseline and follow-up(an interval of more than 8months) coronary angiographic 
data in patients with multiple complex coronary plaques characterized by thrembus, 
ulceration, plaque irregularity, and impaired flow were compared. Nonculpdt lesion 
changes at the narrowest point defined progression or regression when exceeding 
0.27ram. Results: Single complex coronary plaque were identified in 167 patients(72.9%) 
and multiple complex plaques in the other 62 patients(27.1%). Of the 62 
betients(831esions), the pairs of angiogrephy were reviewed simultaneously in 
43.5%(27patients, 35lesions). The severity of nonculprit complex lesions between base- 
line and follow-up angiography is equal (maximal diameter stenosis; 74±15% vs. 
72±15%, p=0.4). Of 35 noncuiprit complex lesions, 29(82%) remain complex without 
changing into smooth lesion, 1 became totally occluded, and 4 regressed. During the in- 
hospital period, the incidence of cardiac death and urgent bypass surgery was signifi- 
cantly higher among those with multiple complex plaques(6.5% vs. 1.2%, p<0.05). Con- 
clusion: in patients with AMI, 27.1% have multiple complex coronary plaques and in most 
cases a complex lesion showed no changes in the severity and complexity. These results 
may partly explain the association between the presence of multiple complex plaques 
and adverse clinical outcomes after AMI. 
1122B-33 Snow Removal as a Trigger of Sudden Cardiac Death in 
Men of Higher Socioeconomic Status  
Pertha S. Chowdhurv. Barry A. Franklin, Judith A. Boura, L J, Dragovic, Sawait Kanluen, 
Werner Spitz, Jerry Hodak, William W. O'Neill, William Beaumont Hospital, Royal Oak, 
Michigan. 
Background: Major snowstorms are often followed by an increased number of fatal car- 
diovascular events from ischemic heart disease. The increased mortality is generally 
attributed to decreased ambient temperatures, strenuous physical exertion, or both. The 
present study was designed to assess the incidence of sudden cardiac death (SCD) 
before and after two major snowstorms in the greater metropolitan Detroit area, with spe- 
cific reference to snow removal (manual or automated) as a trigger of SCD and the vic- 
tims' socioeconomic status. 
Methods: Records from the medical examiners' Offices from 3 counties comprising the 
metropolitan Detroit area, encompassing a total population of 4.1 million, were examined 
for the weeks prior to, during, and after major snowfalls occurring on January 2, 1999 and 
December 11,2000. Only those individuals who experienced SCD secondary to athere- 
sclerotic cardiovascular disease were included in the analyses. Victims were stratified by 
socioeconomic status based on the average annual household income of their zip code: 
Group A < $50,000/yr; and, Group B > $50,000/yr. 
Results: Comparing the weeks prior to, during, and after the snowstorms, there was a 
significant increase in SCD in Group B (32 vs 66 vs 55), but not in Group A (41 vs 36 vs 
41) (p = 0.006). Average temperatures for these weeks were 27 °, 21 °, and 14°F, respec- 
tively. There was no difference in the ages of the victims. For both snowstorms, exertion- 
related SCDs versus total SCDs as a function of time were: 
Time frame Exertion Related SCD Total SCD Percent 
Week prior to storm 2 a 72 2.7 
Week of storm 24 b 103 23.3 
Week after storm 17 c 96 17.7 
Snow removal related deaths: al/2; b22/24 c13/17 
Considering all victims of SCD (n = 271), those who died during or immediately after 
exertion (n = 43) were predominantly male (93 vs 63%, p = 0.001) and more affluent 
(Group B: 79 vs 52%, p = 0.001). Most deaths were related to snow removal (36 of 43). 
Conclusions: This is the largest number of deaths after snow removal (n = 36) reported 
to date, and the first demonstration that a higher socioeconomic status characterizes this 
cohort. These data have important public health implications to reduce exertion-related 
SCD in populations at risk. 
1122B-34 Mul t i foca l  P laque Instabi l i ty  Corre lates  With Elevated C- 
Reactive Protein 
Harish R. Chandra. Gilbert Raft, John Fry, Simon Dixon, William W. O'Neill, James A. 
Goldstein, William Beaumont Hospital, Royal Oak, Michigan. 
Background: Patients with acute coronary syndromes (ACS) may manifest multiple 
unstable plaques on angiography, suggesting a systemic destabilizing process such as 
inflammation exerting adverse influences throughout diseased vessels. Whether C-reac- 
tive protein (CRP), a marker of inflammation and predictor of clinical outcomes in ACS, 
correlates with angiographic patterns of plaque instability has not been elucidated. Meth- 
ods: In 73 patients with ACS, angiograms were analyzed for the presence of unstable 
plaques defined according to complexity criteria including: filling defects, ulceration or 
flow impairment. Angiograms were scored as showing (a) no complex lesions, (b) one 
complex culprit lesion, or (c) multiple complex lesions. High-sensitivity CRP was drawn 
on admission and patients grouped according to CRP levels (tertiles). Results: Angio- 
graphic analysis documented a single unstable plaque in 30 (41%) pts, multiple complex 
lesions in 28 (38%) cases and no complex plaques in 9 (12%) others. The magnitude of 
CRP elevation correlated with the presence of multiple unstable plaques, as patients with 
the highest (upper tertile) CRP levels had a significantly greater number of complex 
lesions than patients in the lowest CRP tertile (p=0.05). Conclusion: The present find- 
ings support those of prior studies demonstrating multifocal plaque instability in patients 
with ACS. These data demonstrate for the first time a significant correlation between mul- 
tifocal plaque instability and CRP levels, suggesting that the magnitude of inflammation 
influences the extent of coronary plaque instability. 
